Online tools for predicting melanoma survival: Including sentinel node status as a variable improves prediction accuracy

Serigne Lo; Alexander H. R. Varey; Mary‐Ann El Sharouni; Richard A Scolyer; John F. Thompson

doi:10.1111/jdv.19524

Related publications

Letter2023

Knowledge of sentinel lymph node status improves accuracy when predicting melanoma mortality and selecting patients for adjuvant immunotherapy

Serigne Lo, Alexander H. R. Varey, Mary‐Ann El Sharouni, Richard A Scolyer, John F. Thompson

Article2023

In memoriam: <scp>Roy J. Shephard</scp>, <scp>MD</scp>, <scp>PhD</scp>, <scp>DPE</scp> (1929–2023)

Peter T. Katzmarzyk, Claude Bouchard

American Journal of Human Biology

Article2025

Novel <scp>ADAMTS13</scp> Mutation in a Patient With Congenital <scp>TTP</scp> Diagnosed in Pregnancy

William Frank Mawalla, Clara Chamba, Ahlam Nasser, I Jonathan, Emmanuel Josephat, Mbonea Yonazi, Zainab Yusuph, Elena Bresin, Giuseppe Remuzzi, Lucio Luzzatto

Letter2024

Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status

Roger Olofsson Bagge, Rasmus Mikiver, Michael A. Marchetti, Serigne Lo, Alexander C.J. van Akkooi, Daniel G. Coit, Christian Ingvar, Karolin Isaksson, Richard A Scolyer, John F. Thompson, Alexander H. R. Varey, Sandra L. Wong, Johan Lyth, Edmund K. Bartlett

Article2020

Quantifying the additional prognostic value of sentinel lymph node status over established clinicopathologic primary tumor features for predicting survival outcomes in melanoma patients.

Serigne Lo, Mary‐Ann El Sharouni, Karijn P.M. Suijkerbuijk, Tasnia Ahmed, Witkamp Arjen, Anne Ε. Cust, V. Sigurdsson, P. J. van Diest, Richard A Scolyer, Carla H. van Gils, John F. Thompson